Thymmune Therapeutics Is A Biotechnology Company Located In Cambridgemassachusettsthe Company Focuses On Restoring Immune Function Through Thymic Cell Engineeringutilizing A Machine Learning Driven Platform To Develop Scalable Therapies For Immune System Disorders And Age Related Immune Decline Thymmune Addresses Thymus Gland Dysfunctionwhich Can Lead To Immunodeficienciesautoimmune Diseasesand Immune Agingtheir Approach Involves Using Induced Pluripotent Stem Cellipscderived Thymic Cells To Create Off The Shelf Treatmentsthe Company Is Advancing Therapies Through Preclinical Studieswith A Pipeline Targeting Immunodeficienciestransplant Related Complicationsautoimmune Disordersand Aging Related Immune Decline Led By Founder And Ceo Stan Wangmdphdthymmune S Team Includes Experts In Stem Cell Biology And Biopharmaceuticalsthe Company Has Secured $7 Million In Seed Funding To Support Its Research And Development Effortsemphasizing Translational Research And Readiness For Clinical Stage Cell Therapies
No conferences found for this company.
| Company Name | Timmune Biotech Inc |
| Country |
China
|
| Address | N/A |
| Telephone | N/A |
| N/A |
